相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
Akira Tokumura et al.
International Journal of Medical Sciences (2012)
IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
Doanh Le Huu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
Petra Keul et al.
CIRCULATION RESEARCH (2011)
Implications of TNF-α in the pathogenesis and management of GVHD
John E. Levine
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Inducible Costimulator Ligand Regulates Bleomycin-Induced Lung and Skin Fibrosis in a Mouse Model Independently of the Inducible Costimulator/Inducible Costimulator Ligand Pathway
Chihiro Tanaka et al.
ARTHRITIS AND RHEUMATISM (2010)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
S1P3 confers differential Sip-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development
Erin E. Donovan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
Zhaohong Yin et al.
RHEUMATOLOGY (2010)
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR
Guangwei Liu et al.
NATURE IMMUNOLOGY (2009)
Murine models of chronic graft-versus-host disease: Insights and unresolved issues
Yu-Waye Chu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Myeloid-derived suppressor cells in inflammatory bowel disease:: A new immunoregulatory pathway
Lydia A. Haile et al.
GASTROENTEROLOGY (2008)
Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-β/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway
Shizhong Bu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Impaired Initiation of Contact Hypersensitivity by FTY720
Daiki Nakashima et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
The alliance of sphingosine-1-phosphate and its receptors in immunity
Juan Rivera et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Follicular shuttling of marginal zone B cells facilitates antigen transport
Guy Cinamon et al.
NATURE IMMUNOLOGY (2008)
CD11b+Ly-6Chi suppressive monocytes in experimental autoimmune encephalomyelitis
Bing Zhu et al.
JOURNAL OF IMMUNOLOGY (2007)
MyD88-dependent expansion of an immature GR-1+ CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J. Delano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Effect of TGF-β/Smad signaling pathway on lung myofibroblast differentiation
Li Gu et al.
ACTA PHARMACOLOGICA SINICA (2007)
Cutaneous gene expression by DNA microarray in murine sclerodermatous craft-versus-host disease, a model for human scleroderma
Lixin Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
Jerzy-Roch Nofer et al.
CIRCULATION (2007)
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P(3) and smad3 signaling
Christina D. Keller et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
PTEN regulates fibroblast elimination during collagen matrix contraction
Richard Seonghun Nho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress
VP Makarenkova et al.
JOURNAL OF IMMUNOLOGY (2006)
The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity
E Sawicka et al.
JOURNAL OF IMMUNOLOGY (2005)
Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement
KA Vora et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network
H Rosen et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Characteristics of Animal Models for Scleroderma
Toshiyuki Yamamoto
CURRENT RHEUMATOLOGY REVIEWS (2005)
Degenerative lumbar spondylolisthesis with spinal stenosis - A prospective long-term study comparing fusion and pseudarthrosis
MB Kornblum et al.
SPINE (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1÷ endothelial cells in splenic marginal sinus organization
I Girkontaite et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function
V Brinkmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone
G Cinamon et al.
NATURE IMMUNOLOGY (2004)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity
V Brinkmann et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: Cutaneous cytokines, chemokines, and immune cell activation
Y Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
